US reclassifies some Marijuana products as less dangerous; hearing set for June 2026

The US Department of Justice and Drug Enforcement Administration have announced a change in how marijuana is treated under US law. Some marijuana products, including FDA-approved cannabis-based medicines and medical marijuana regulated by state licences, are now classified as less dangerous drugs under Schedule III. This move recognises the medical value and lower risk of marijuana for certain products, allowing for easier research and potentially clearer guidelines for doctors.